Abstract Details

Title Does Immunotherapy Work for New-Onset Refractory Status Epilepticus? A Pooled-Analysis of Available Literature

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 216

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jennifer DeWolfe, DO (University of Alabama At Birmingham) PRESENTER	No disclosure on file
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN (University of Alabama At Birmingham)	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.

��ɫ����